Archive | News

 September 21, 2017

JSK Therapeutics™ wins $2,000,000 Phase II SBIR award

May 2018 

JSK Therapeutics™ sponsors The Leukemia & Lymphoma Society Function

September 2019

Dr. Paul Shami presented at The VI International Workshop on "Nitric oxide in cancer and beyond” will be held in New York, during September 20-22, 2019

Development of JS-K for the treatment of cancer

Paul J. Shami, MD

Division of Hematology and Hematologic Malignancies, Huntsman Cancer

Institute, University of Utah, Salt Lake City, UT